Ardena expands its global footprint with the acquisition of a state-of-the-art drug product manufacturing facility in Somerset, New Jersey. This addition enhances Ardena’s ability to support clients with end-to-end drug development and manufacturing services while establishing a foundation for future bioanalytical capabilities in North America.
